Literature DB >> 22897416

Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies.

T Xu1, Y-H Zhang.   

Abstract

BACKGROUND: Psoriasis is a common, chronic, relapsing, inflammatory skin disorder. Observational studies suggest an association between psoriasis and the incidence of stroke or myocardial infarction (MI). However, whether psoriasis is an independent risk factor for these two vascular events remains controversial.
OBJECTIVES: To evaluate the association of psoriasis with stroke and MI by conducting a meta-analysis of cohort studies.
METHODS: Cohort studies were searched in MEDLINE (Pubmed), EMBASE and Cochrane Library from their inception to March 2012. Stroke and MI were considered as a composite endpoint. Two authors independently extracted information on the characteristics of the study participants, follow-up range and control for potential confounding factors. A random-effects model was used to calculate the overall combined risk estimates.
RESULTS: Seven cohort studies were included in the meta-analysis. On the basis of cohort characteristics, five of them were considered good quality and two were fair. The overall combined relative risk for psoriasis and composite vascular endpoint was 1·2 (95% confidence interval 1·1-1·31). Subgroup analysis maintained this significance with respect to stroke and MI individually. Sensitivity analysis and 'trim and fill' method yielded similar results. No evidence of publication bias was observed.
CONCLUSIONS: This meta-analysis of cohort studies suggests that psoriasis significantly increases the risk of stroke and MI. The increase is probably independent of conventional cardiovascular risk factors.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2012        PMID: 22897416     DOI: 10.1111/bjd.12002

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  32 in total

1.  Psoriasis and cardiovascular risk assessment in primary care.

Authors:  Christopher Barraclough; Sheila Clark
Journal:  Br J Gen Pract       Date:  2015-09       Impact factor: 5.386

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.

Authors:  Neal Bhatia; Andrew Blauvelt; Marc Brown; Whitney High; Craig T Leonardi; Ted Rosen; Linda Stein Gold; Eggert Stockfleth; Bruce Strober; Neil A Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

3.  Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.

Authors:  Renli Teng; Mirjana Kujacic; Judith Hsia
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

Review 4.  Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis.

Authors:  S Upala; A Sanguankeo
Journal:  Int J Obes (Lond)       Date:  2015-04-29       Impact factor: 5.095

5.  Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.

Authors:  Moa P Lee; Rishi J Desai; Yinzhu Jin; Gregory Brill; Alexis Ogdie; Seoyoung C Kim
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

Review 6.  Endothelial Dysfunction in Psoriasis: An Updated Review.

Authors:  Panagiota Anyfanti; Anastasia Margouta; Kyriakos Goulas; Maria Gavriilaki; Elizabeth Lazaridou; Aikaterini Patsatsi; Eugenia Gkaliagkousi
Journal:  Front Med (Lausanne)       Date:  2022-06-10

7.  Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.

Authors:  Zhen-Xing Zhou; Jian-Kui Chen; Yan-Ying Hong; Ru Zhou; Dong-Mei Zhou; Li-Yun Sun; Wen-Li Qin; Tian-Cheng Wang
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

Review 8.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

Review 9.  Psoriasis: Comorbidities.

Authors:  Fumikazu Yamazaki
Journal:  J Dermatol       Date:  2021-03-25       Impact factor: 4.005

Review 10.  Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?

Authors:  Marianne de Brito; Zenas Z N Yiu
Journal:  Am J Clin Dermatol       Date:  2021-07-22       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.